Dr. Michelson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
122 frustuck avenue
Fairfax, CA 94930Phone+1 415-690-6206
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 1993 - 1996
UPMC Medical EducationResidency, Internal Medicine, 1990 - 1993
University of Louisville School of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 1999 - 2026
NM State Medical License 2021 - 2025
IL State Medical License 1993 - 2002
KY State Medical License 1996 - 2000
PA State Medical License 1992 - 1994
Publications & Presentations
PubMed
- 23 citationsEfficacy and safety of the dual SYK/JAK inhibitor cerdulatinib in patients with relapsed or refractory B-cell malignancies: Results of a phase I study.Paul A. Hamlin, Ian W. Flinn, Nina D. Wagner-Johnston, Jan A. Burger, Greg Coffey
American Journal of Hematology. 2019-04-01 - 27 citationsCerdulatinib pharmacodynamics and relationships to tumor response following oral dosing in patients with relapsed/refractory B-cell malignanciesGreg Coffey, Jiajia Feng, Andreas Betz, Anjali Pandey, Matt Birrell
Clinical Cancer Research. 2019-02-15 - 26 citationsA phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemiaJeffrey E. Lancet, Gail J. Roboz, Larry D. Cripe, Glenn Michelson, Judith A. Fox
Haematologica. 2015-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
